Search

Suzanne Marie Noakes

Examiner (ID: 17824)

Most Active Art Unit
1656
Art Unit(s)
1656, 1653
Total Applications
1691
Issued Applications
1090
Pending Applications
193
Abandoned Applications
452

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5533478 [patent_doc_number] => 20090233266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'STRUCTURE OF THE HEPATITIS C VIRUS NS2 PROTEIN' [patent_app_type] => utility [patent_app_number] => 11/817782 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14926 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233266.pdf [firstpage_image] =>[orig_patent_app_number] => 11817782 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/817782
STRUCTURE OF THE HEPATITIS C VIRUS NS2 PROTEIN Mar 8, 2006 Abandoned
Array ( [id] => 274063 [patent_doc_number] => 07560227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-14 [patent_title] => 'Biomarkers of vulnerable atherosclerotic plaques and methods of use' [patent_app_type] => utility [patent_app_number] => 11/365127 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 9435 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/560/07560227.pdf [firstpage_image] =>[orig_patent_app_number] => 11365127 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/365127
Biomarkers of vulnerable atherosclerotic plaques and methods of use Feb 27, 2006 Issued
Array ( [id] => 4461103 [patent_doc_number] => 07894996 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Structure of the hepatitis C NS5A protein' [patent_app_type] => utility [patent_app_number] => 11/817309 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 20 [patent_no_of_words] => 18550 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/894/07894996.pdf [firstpage_image] =>[orig_patent_app_number] => 11817309 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/817309
Structure of the hepatitis C NS5A protein Feb 27, 2006 Issued
Array ( [id] => 4964846 [patent_doc_number] => 20080107666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Non-Glycosylated Recombinant Collagen-Like Polypeptides' [patent_app_type] => utility [patent_app_number] => 11/817006 [patent_app_country] => US [patent_app_date] => 2006-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6816 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20080107666.pdf [firstpage_image] =>[orig_patent_app_number] => 11817006 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/817006
Non-glycosylated recombinant collagen-like polypeptides Feb 21, 2006 Issued
Array ( [id] => 5625866 [patent_doc_number] => 20060264371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Treatment' [patent_app_type] => utility [patent_app_number] => 11/356453 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8096 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20060264371.pdf [firstpage_image] =>[orig_patent_app_number] => 11356453 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/356453
Treatment Feb 16, 2006 Abandoned
Array ( [id] => 4840325 [patent_doc_number] => 20080280811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Compositions and Methods for Treating Vascular Permeability' [patent_app_type] => utility [patent_app_number] => 11/884503 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17436 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20080280811.pdf [firstpage_image] =>[orig_patent_app_number] => 11884503 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/884503
Compositions and methods for treating vascular permeability Feb 15, 2006 Issued
Array ( [id] => 4887544 [patent_doc_number] => 20080261876 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Method for Purifying Marine Collagen and the Processing Thereof Into Porous Sponges' [patent_app_type] => utility [patent_app_number] => 11/817044 [patent_app_country] => US [patent_app_date] => 2006-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2026 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20080261876.pdf [firstpage_image] =>[orig_patent_app_number] => 11817044 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/817044
Method for purifying marine collagen and the processing thereof into porous sponges Feb 13, 2006 Issued
Array ( [id] => 5700621 [patent_doc_number] => 20060217306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Systemic treatment of infections with defensins' [patent_app_type] => utility [patent_app_number] => 11/350321 [patent_app_country] => US [patent_app_date] => 2006-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5927 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217306.pdf [firstpage_image] =>[orig_patent_app_number] => 11350321 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/350321
Systemic treatment of infections with defensins Feb 7, 2006 Abandoned
Array ( [id] => 283411 [patent_doc_number] => 07555415 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-30 [patent_title] => 'Methods for the design of estrogen receptor ligands' [patent_app_type] => utility [patent_app_number] => 11/334982 [patent_app_country] => US [patent_app_date] => 2006-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 142818 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 324 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/555/07555415.pdf [firstpage_image] =>[orig_patent_app_number] => 11334982 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/334982
Methods for the design of estrogen receptor ligands Jan 17, 2006 Issued
Array ( [id] => 5655785 [patent_doc_number] => 20060141520 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Methods for the treatment of metabolic disorders, including obesity and diabetes' [patent_app_type] => utility [patent_app_number] => 11/331549 [patent_app_country] => US [patent_app_date] => 2006-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 29490 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20060141520.pdf [firstpage_image] =>[orig_patent_app_number] => 11331549 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/331549
Methods for the treatment of metabolic disorders, including obesity and diabetes Jan 12, 2006 Abandoned
Array ( [id] => 5733728 [patent_doc_number] => 20060258845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Novel purified polypeptides from Staphylococcus aureus' [patent_app_type] => utility [patent_app_number] => 11/329987 [patent_app_country] => US [patent_app_date] => 2006-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 169 [patent_figures_cnt] => 169 [patent_no_of_words] => 72478 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11329987 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/329987
Purified polypeptides from Staphylococcus aureus Jan 10, 2006 Issued
Array ( [id] => 4994577 [patent_doc_number] => 20070009922 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'Hot start polymerase reaction using a thermolabile blocker' [patent_app_type] => utility [patent_app_number] => 11/324887 [patent_app_country] => US [patent_app_date] => 2006-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16274 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20070009922.pdf [firstpage_image] =>[orig_patent_app_number] => 11324887 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/324887
Hot start polymerase reaction using a thermolabile blocker Jan 3, 2006 Abandoned
Array ( [id] => 6352086 [patent_doc_number] => 20100021987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Compositions, Methods, and Kits for Enhancing Protein Expression' [patent_app_type] => utility [patent_app_number] => 11/794532 [patent_app_country] => US [patent_app_date] => 2005-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 22067 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20100021987.pdf [firstpage_image] =>[orig_patent_app_number] => 11794532 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/794532
Human SUMO-3 for enhancing protein expression Dec 29, 2005 Issued
Array ( [id] => 5672078 [patent_doc_number] => 20060177432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Methods and reagents for protease inhibition' [patent_app_type] => utility [patent_app_number] => 11/311974 [patent_app_country] => US [patent_app_date] => 2005-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11775 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20060177432.pdf [firstpage_image] =>[orig_patent_app_number] => 11311974 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/311974
Methods and reagents for protease inhibition Dec 18, 2005 Abandoned
Array ( [id] => 239126 [patent_doc_number] => 07591841 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-22 [patent_title] => 'Implantable devices for accelerated healing' [patent_app_type] => utility [patent_app_number] => 11/303724 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5074 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/591/07591841.pdf [firstpage_image] =>[orig_patent_app_number] => 11303724 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/303724
Implantable devices for accelerated healing Dec 15, 2005 Issued
Array ( [id] => 197068 [patent_doc_number] => 07638599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Conjugates of membrane translocating agents and pharmaceutically active agents' [patent_app_type] => utility [patent_app_number] => 11/303372 [patent_app_country] => US [patent_app_date] => 2005-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17297 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638599.pdf [firstpage_image] =>[orig_patent_app_number] => 11303372 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/303372
Conjugates of membrane translocating agents and pharmaceutically active agents Dec 15, 2005 Issued
Array ( [id] => 5678327 [patent_doc_number] => 20060183683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Liquid composition of factor VII polypeptides' [patent_app_type] => utility [patent_app_number] => 11/304429 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12514 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183683.pdf [firstpage_image] =>[orig_patent_app_number] => 11304429 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/304429
Liquid composition of factor VII polypeptides Dec 14, 2005 Abandoned
Array ( [id] => 6622805 [patent_doc_number] => 20100003709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Crystal Structure of Enzyme and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/793367 [patent_app_country] => US [patent_app_date] => 2005-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 112795 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20100003709.pdf [firstpage_image] =>[orig_patent_app_number] => 11793367 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/793367
Crystal Structure of Enzyme and Uses Thereof Dec 12, 2005 Abandoned
Array ( [id] => 5563723 [patent_doc_number] => 20090136575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Protein Formulation' [patent_app_type] => utility [patent_app_number] => 11/721192 [patent_app_country] => US [patent_app_date] => 2005-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 24489 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136575.pdf [firstpage_image] =>[orig_patent_app_number] => 11721192 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/721192
Protein formulation Dec 11, 2005 Issued
Array ( [id] => 5834641 [patent_doc_number] => 20060246471 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Compositions and methods for screening pro-apoptotic compounds' [patent_app_type] => utility [patent_app_number] => 11/299139 [patent_app_country] => US [patent_app_date] => 2005-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 36666 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246471.pdf [firstpage_image] =>[orig_patent_app_number] => 11299139 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/299139
Compositions and methods for screening pro-apoptotic compounds Dec 8, 2005 Abandoned
Menu